Partial improvement of solar urticaria after omalizumab

Previously classified into 6 types (I-VI) based on the action spectrum, solar urticaria is now divided into 2 types: type I and type II.1 Type I defines patients who have precursors located in the serum, plasma, or cutaneous tissue fluid that become photoallergens once activated by the appropriate w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of allergy and clinical immunology 2010-02, Vol.125 (2), p.490-491
Hauptverfasser:	Waibel, Kirk H., MD, Reese, Drew A., MD, Hamilton, Robert G., PhD, Devillez, Richard L., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Allergies Allergy and Immunology Anti-Allergic Agents - therapeutic use Antibodies, Anti-Idiotypic Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Drug therapy Humans Immunoglobulin E - blood Male Omalizumab Patients Photosensitivity Disorders - drug therapy Photosensitivity Disorders - etiology Photosensitivity Disorders - immunology Sunlight - adverse effects Urticaria - drug therapy Urticaria - etiology Urticaria - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!